Kevin Danahy's most recent trade in Pulse Biosciences Inc was a trade of 650 Common Stock done . Disclosure was reported to the exchange on July 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Kevin Danahy | Chief Commercial Officer | 03 Jul 2024 | 650 | 36,537 (0%) | 0% | - | Common Stock | ||
| Pulse Biosciences Inc | Kevin Danahy | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jul 2024 | 325 | 325 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Kevin Danahy | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jul 2024 | 325 | 325 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Kevin Danahy | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2023 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin Danahy | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 30 Sep 2022 | 6,500 | 6,500 (0%) | 0% | 2.3 | 14,950 | Common Stock |
| Pulse Biosciences Inc | Kevin Danahy | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Kevin Danahy | Chief Commercial Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |